Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Kohjin Bio CoTSE:177A -1.00%19 FCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates TSE:177A with a GF Score™ of 19/100. The stock has 4 warning signs investors should review. Among 955 Biotechnology companies, Kohjin Bio Co ranks better than 70.89% on this metric.
The historical data trend for Kohjin Bio Co's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:177A vs VRTX, REGN, RVMD: FCF Margin % Comparison
For the Biotechnology subindustry, Kohjin Bio Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kohjin Bio Co FCF Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Kohjin Bio Co's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Kohjin Bio Co's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kohjin Bio Co (TSE:177A) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Kohjin Bio Co and its competitors. According to the industry distribution chart, Kohjin Bio Co ranks #278 out of 955 companies in the Biotechnology industry, placing it in the top 29.1%.
Is Kohjin Bio Co's FCF Margin % too high?
Kohjin Bio Co's current FCF Margin % is 0.00%. Based on the distribution chart, Kohjin Bio Co ranks #278 out of 955 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Kohjin Bio Co has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Kohjin Bio Co's FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Kohjin Bio Co ranks #278 out of 955 companies for FCF Margin %. This puts Kohjin Bio Co in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Kohjin Bio Co and its competitors. Kohjin Bio Co's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kohjin Bio Co stock overvalued right now?
Kohjin Bio Co (TSE:177A) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Kohjin Bio Co's overall GF Score™ is 19/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Kohjin Bio Co (TSE:177A), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Kohjin Bio Co Ltd is engaged in development, manufacture and sale of culture media (growing environments used for culturing microorganisms and cells) and contract manufacturing of processed cell products. It has manufacturing and sales of animal blood, sera, tissue culture media, media for microbiology testing, in vitro diagnostic agents, and cosmetics.
19GF Score
Get the complete analysis for TSE:177A
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:177A has been successfully added to your 
